• market on mobile

Pause Refresh

Latest News and Updates on "received"

  • Lupin gains after US drug regulator nod for generic drug
  • Lupin gains after US drug regulator nod for generic drug
    Mumbai,Feb 06, 09:19

    The stock advanced 1.3 percent after the company received final approval for its Triamcinolone Acetonide Cream USP, from USFDA to market a generic equivalent of Mylan Pharmaceuticals Inc.s Triamcinolone Acetonide Cream....

  • Dishman Pharmaceuticals edges higher
  • Dishman Pharmaceuticals edges higher
    Mumbai,Feb 02, 11:24

    The stock gained 3 percent after the company said that it has received Establishment Inspection Report from the US drug regulator for Bavla facility....

  • Lupin gains after receiving USFDA approval
  • Lupin gains after receiving USFDA approval
    Mumbai,Jan 11, 15:14

    The stock jumped 2.2 percent after the company announced that it has received final approval for its Desoximetasone Cream from the United States Food and Drug Administration....

  • MEP Infra strengthens 3.6%
  • MEP Infra strengthens 3.6%
    Mumbai,Jan 03, 10:26

    The stock jumped after the company received user fee collection rights at Brijghat fee plaza in Uttar Pradesh....

  • Lupin nudges higher
  • Lupin nudges higher
    Mumbai,Jan 02, 13:52

    The stock advanced 0.8 percent after the company announced that it has received final approval for its Cevimeline Hydrochloride Capsules, 30 mg from the US drug regulator....

  • Bombay Dyeing gains
  • Bombay Dyeing gains
    Mumbai,Jan 02, 11:10

    The stock jumped 2.8 percent after the company entered into an agreement for sale of land & building, some specific utility machineries and a company owned flat....

  • Ujaas Energy energizes
  • Ujaas Energy energizes
    Mumbai,Jan 02, 10:24

    The stock jumped 3.15 percent after the company announced that it has received letter of Intent from MOIL for 5 megawatts solar power photovoltaic plant in Maharashtra....

  • Lupin inches up
  • Lupin inches up
    Mumbai,Dec 29, 14:30

    The stock gained 0.6 percent after the company said it has received tentative approval from the US drug regulator to market a generic version of Salix Pharmaceuticals lncs Giazo tablets, 1.1 gm....



Infosys crawls higher after completing acquisition of Brilliant Basics

The stock is now quoted at Rs 889 on the BSE.


INTRADAY CHART

Prev. Close : 32272.61
You need to upgrade your Flash Player
Prev. Close : 10085.4
You need to upgrade your Flash Player



feedback